NBIX

Neurocrine Biosciences, Inc. (NBIX), headquartered in San Diego, California, is a prominent biopharmaceutical firm focused on innovating treatments for neurological, endocrine, and psychiatric disorders. With a diverse and advanced pipeline, the company is actively pursuing therapies for conditions such as Parkinson's disease and epilepsy, aiming to fulfill crucial unmet medical needs. Neurocrine's dedication to scientific innovation, coupled with strategic collaborations, positions it for robust growth in the biopharmaceutical sector and reinforces its commitment to improving patient outcomes on a global scale.